NASDAQ · SINT
SiNtx Technologies, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for SINT: Nov 05, 2026
SiNtx Technologies, Inc. Common Stock is expected to report earnings on 11/05/2026 after market close. The report will be for the fiscal Quarter ending Sep 2026. According to Zacks Investment Research, based on 2 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.31. The reported EPS for the same quarter last year was $-3.46.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.31 | $-0.28 | $-0.33 | 2 |
| Dec 2026 | $-0.35 | $-0.32 | $-0.38 | 2 |
| Mar 2027 | $-0.30 | $-0.30 | $-0.30 | 1 |
| Jun 2027 | $-0.31 | $-0.31 | $-0.31 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
Zacks · Fintel- Zacks · Oct 8, 11:00 AM EDTWhat Makes SINTX TECHNOLOGIES (SINT) a New Buy StockSINTX TECHNOLOGIES (SINT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Zacks · Aug 19, 12:00 PM EDTSINTX TECHNOLOGIES (SINT) Moves to Buy: Rationale Behind the UpgradeSINTX TECHNOLOGIES (SINT) has been upgraded to a Zacks Rank #2 (Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.
- Zacks · Aug 6, 7:10 PM EDTGlobus Medical (GMED) Q2 Earnings and Revenues Surpass EstimatesGlobus Medical (GMED) delivered earnings and revenue surprises of +19.64% and +0.35%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 5, 7:25 AM EDTLivaNova (LIVN) Q2 Earnings and Revenues Beat EstimatesLivaNova (LIVN) delivered earnings and revenue surprises of +16.67% and +2.90%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Aug 3, 6:45 PM EDTClearPoint Neuro, Inc. (CLPT) Reports Q2 Loss, Misses Revenue EstimatesClearPoint Neuro (CLPT) delivered earnings and revenue surprises of -31.03% and -16.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · Jul 29, 8:25 AM EDTAxoGen (AXGN) Tops Q2 Earnings and Revenue EstimatesAxoGen (AXGN) delivered earnings and revenue surprises of +33.33% and +4.31%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 15, 9:15 AM EDTPAVmed Inc. (PAVM) Reports Q1 Loss, Lags Revenue EstimatesPAVmed (PAVM) delivered earnings and revenue surprises of -69.57% and -78.00%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 14, 5:15 PM EDTSangamo Therapeutics (SGMO) Reports Q1 Loss, Misses Revenue EstimatesSangamo (SGMO) delivered earnings and revenue surprises of -100.00% and -84.82%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 13, 6:10 PM EDTRapid Micro Biosystems, Inc. (RPID) Reports Q1 Loss, Tops Revenue EstimatesRapid Micro Biosystems (RPID) delivered earnings and revenue surprises of -24.00% and +6.69%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 7, 7:05 PM EDTArtivion (AORT) Q1 Earnings and Revenues Surpass EstimatesArtivion (AORT) delivered earnings and revenue surprises of +33.33% and +0.33%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Zacks · May 5, 7:25 AM EDTWaters (WAT) Beats Q1 Earnings and Revenue EstimatesWaters (WAT) delivered earnings and revenue surprises of +17.11% and +5.20%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
- Fintel · Apr 13, 10:58 AM EDTHC Wainwright & Co. Initiates Coverage of Sintx Technologies (SINT) with Buy RecommendationFintel reports that on April 13, 2026, HC Wainwright & Co. initiated coverage of Sintx Technologies (NasdaqCM:SINT) with a Buy recommendation. Analyst Price Forecast Suggests 508.96% Upside
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for SiNtx Technologies, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.